
Aardvark Therapeutics Executives Increase Their Holdings

I'm PortAI, I can summarize articles.
Aardvark Therapeutics' CEO Lee Tien-Li and CFO Sun Nelson have increased their holdings in the company. Lee Tien-Li purchased 7,000 shares for $101,395, raising his direct ownership to 1,551,613 shares and indirect ownership to 1,474,028 shares. Sun Nelson acquired 3,000 shares for $43,200, bringing his direct ownership to 108,484 shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

